Amid burnout crisis in private law, new legal design methodology emerges. ST. PETERSBURG, FL, UNITED STATES, February ...
PRINCETON, N.J., Feb. 25, 2026 /PRNewswire/ -- Hoot Health today announced its entry into the pharmaceutical market with an AI-powered, physician-led patient education engine designed to address one ...
Since BridgeBio scored FDA approval for cardiomyopathy drug Attruby 15 | When BridgeBio presented its quarterly report on Tuesday, it laid out expectations on the potential threat of generic pricing ...
New podcast season to spotlight P&L-focused leaders blazing the trail to purposeful procurement ...
Q4 2025 earnings call recap: pipeline milestones, PROTAC FDA/PDUFA timeline, 2026 data catalysts, and cash runway—read now.
The list price of Wegovy will be cut in half on January 1, 2027, plummeting from around $1,350 to $675 a month. The cost of ...
Asianet Newsable on MSN
Novavax Q4 earnings preview: Wall Street expects wider losses amid diversification efforts
According to data from Fiscal AI, Novavax is expected to report a quarterly loss per share of $0.55, higher than the loss of ...
Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.
In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus’ novel ...
Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a new--generation ...
Agreement worth up to $495 million is part of a growing number of Chinese deals with global pharma giants as the country ...
Protara Therapeutics has touted a 66% complete response (CR) rate for its cell therapy among certain bladder cancer patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results